Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-13
DOI
10.1038/s41598-019-55641-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thioredoxin Reductase as a Novel and Efficient Plasma Biomarker for the Detection of Non-Small Cell Lung Cancer: a Large-scale, Multicenter study
- (2019) Suofu Ye et al. Scientific Reports
- Education and gastric cancer risk – An individual participant data meta‐analysis in the StoP project consortium
- (2019) Matteo Rota et al. INTERNATIONAL JOURNAL OF CANCER
- The role of thioredoxin system in cancer: strategy for cancer therapy
- (2019) Jin-Jing Jia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The thioredoxin system and cancer therapy: a review
- (2019) Fariba Mohammadi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cancer incidence and mortality in China, 2014
- (2018) Wanqing Chen et al. Chinese Journal of Cancer Research
- Redox regulation of protein kinase C by selenometabolites and selenoprotein thioredoxin reductase limits cancer prevention by selenium
- (2018) Rayudu Gopalakrishna et al. FREE RADICAL BIOLOGY AND MEDICINE
- Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
- (2018) Junmin Zhang et al. MEDICINAL RESEARCH REVIEWS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario
- (2018) A. L. Mahar et al. Current Oncology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the Thioredoxin System for Cancer Therapy
- (2017) Junmin Zhang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The serum activity of thioredoxin reductases 1 (TrxR1) is correlated with the poor prognosis in EGFR wild-type and ALK negative non-small cell lung cancer
- (2017) Gong Chen et al. Oncotarget
- Plasma thioredoxin reductase activity, a diagnostic biomarker, is up-regulated in resectable non-small cell lung cancers
- (2017) Ming Zhou et al. Translational Cancer Research
- The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma
- (2016) Maryam Sobhani et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer
- (2016) Yao Liang et al. Oncotarget
- Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress
- (2016) Chaoran Dong et al. Scientific Reports
- The thioredoxin system in breast cancer cell invasion and migration
- (2016) Maneet Bhatia et al. Redox Biology
- Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer
- (2015) Li-Kui Yin et al. Asian Pacific Journal of Cancer Prevention
- Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases
- (2015) Yang-Chun Zhou et al. Asian Pacific Journal of Cancer Prevention
- Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma
- (2015) Chunyan Li et al. Oncotarget
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The thioredoxin antioxidant system
- (2013) Jun Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thioredoxin System in Cell Death Progression
- (2012) Jun Lu et al. ANTIOXIDANTS & REDOX SIGNALING
- Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis
- (2012) Bradley A. Carlson et al. CARCINOGENESIS
- The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
- (2011) Anna Maria Berghella et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systemic therapy for advanced gastric cancer: a clinical practice guideline
- (2011) M. MacKenzie et al. Current Oncology
- Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent
- (2011) Lihui Wang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Thioredoxin and thioredoxin reductase: Current research with special reference to human disease
- (2010) Arne Holmgren et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Focus on mammalian thioredoxin reductases — Important selenoproteins with versatile functions
- (2009) Elias S.J. Arnér BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation